Dermal absorption of camphor, menthol, and methyl salicylate in humans

Debra Martin, Jennifer Valdez, James Boren, Michael Mayersohn

Research output: Contribution to journalArticle

46 Citations (Scopus)

Abstract

Camphor, menthol, and methyl salicylate occur in numerous over-the-counter products. Although extensively used, there have been no estimates of human exposure following administration via dermal application. Furthermore, there is little information about the pharmacokinetics of those compounds. The authors report the plasma concentrations of the intact compounds as a function of dose following dermal patch application. Three groups of 8 subjects (4 male, 4 female) applied a different number of commercial patches (2, 4, or 8) to the skin for 8 hours. Plasma samples were assayed using sensitive and selective gas-chromatographic methods. For the 8-patch group, the average maximum plasma concentrations (Cmax ± SD) were 41.0 ±5.8 ng/mL, 31.9 ± 8.8 ng/mL, and 29.5 ± 10.5 ng/mL for camphor, menthol, and methyl salicylate, respectively. The corresponding values for the 4-patch group were 26.8 ± 7.2 ng/mL, 19.0 ±5.4 ng/mL, and 16.8 ± 6.8 ng/mL. The harmonic mean terminal half-lives were 5.6 ± 1.3 hours, 4.7 ± 1.6 hours, and 3.0 ± 1.2 hours for camphor, menthol, and methyl salicylate, respectively. The 2-patch group had measurable but low plasma concentrations of each compound. Low-dose dermal application for an extended time results in low plasma concentrations of all 3 compounds. Four and 8 patches, when applied for 8 hours, gave measurable and nearly proportional plasma concentrations. Although unable to determine the absolute dermal bioavailability of these compounds, there appears to be relatively low systemic exposure to these potentially toxic compounds, even when an unrealistically large number of patches are applied for an unusually long time.

Original languageEnglish (US)
Pages (from-to)1151-1157
Number of pages7
JournalJournal of Clinical Pharmacology
Volume44
Issue number10
DOIs
StatePublished - Oct 2004

Fingerprint

Menthol
Camphor
Skin Absorption
Skin
Cutaneous Administration
Poisons
Biological Availability
methyl salicylate
Pharmacokinetics
Gases

Keywords

  • Absorption
  • Camphor
  • Dermal patches
  • Menthol
  • Methyl salicylate
  • Toxicity

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Dermal absorption of camphor, menthol, and methyl salicylate in humans. / Martin, Debra; Valdez, Jennifer; Boren, James; Mayersohn, Michael.

In: Journal of Clinical Pharmacology, Vol. 44, No. 10, 10.2004, p. 1151-1157.

Research output: Contribution to journalArticle

Martin, Debra ; Valdez, Jennifer ; Boren, James ; Mayersohn, Michael. / Dermal absorption of camphor, menthol, and methyl salicylate in humans. In: Journal of Clinical Pharmacology. 2004 ; Vol. 44, No. 10. pp. 1151-1157.
@article{d1650a9e2ab04e50b5c9fb8b2e97d078,
title = "Dermal absorption of camphor, menthol, and methyl salicylate in humans",
abstract = "Camphor, menthol, and methyl salicylate occur in numerous over-the-counter products. Although extensively used, there have been no estimates of human exposure following administration via dermal application. Furthermore, there is little information about the pharmacokinetics of those compounds. The authors report the plasma concentrations of the intact compounds as a function of dose following dermal patch application. Three groups of 8 subjects (4 male, 4 female) applied a different number of commercial patches (2, 4, or 8) to the skin for 8 hours. Plasma samples were assayed using sensitive and selective gas-chromatographic methods. For the 8-patch group, the average maximum plasma concentrations (Cmax ± SD) were 41.0 ±5.8 ng/mL, 31.9 ± 8.8 ng/mL, and 29.5 ± 10.5 ng/mL for camphor, menthol, and methyl salicylate, respectively. The corresponding values for the 4-patch group were 26.8 ± 7.2 ng/mL, 19.0 ±5.4 ng/mL, and 16.8 ± 6.8 ng/mL. The harmonic mean terminal half-lives were 5.6 ± 1.3 hours, 4.7 ± 1.6 hours, and 3.0 ± 1.2 hours for camphor, menthol, and methyl salicylate, respectively. The 2-patch group had measurable but low plasma concentrations of each compound. Low-dose dermal application for an extended time results in low plasma concentrations of all 3 compounds. Four and 8 patches, when applied for 8 hours, gave measurable and nearly proportional plasma concentrations. Although unable to determine the absolute dermal bioavailability of these compounds, there appears to be relatively low systemic exposure to these potentially toxic compounds, even when an unrealistically large number of patches are applied for an unusually long time.",
keywords = "Absorption, Camphor, Dermal patches, Menthol, Methyl salicylate, Toxicity",
author = "Debra Martin and Jennifer Valdez and James Boren and Michael Mayersohn",
year = "2004",
month = "10",
doi = "10.1177/0091270004268409",
language = "English (US)",
volume = "44",
pages = "1151--1157",
journal = "Journal of Clinical Pharmacology",
issn = "0091-2700",
publisher = "SAGE Publications Inc.",
number = "10",

}

TY - JOUR

T1 - Dermal absorption of camphor, menthol, and methyl salicylate in humans

AU - Martin, Debra

AU - Valdez, Jennifer

AU - Boren, James

AU - Mayersohn, Michael

PY - 2004/10

Y1 - 2004/10

N2 - Camphor, menthol, and methyl salicylate occur in numerous over-the-counter products. Although extensively used, there have been no estimates of human exposure following administration via dermal application. Furthermore, there is little information about the pharmacokinetics of those compounds. The authors report the plasma concentrations of the intact compounds as a function of dose following dermal patch application. Three groups of 8 subjects (4 male, 4 female) applied a different number of commercial patches (2, 4, or 8) to the skin for 8 hours. Plasma samples were assayed using sensitive and selective gas-chromatographic methods. For the 8-patch group, the average maximum plasma concentrations (Cmax ± SD) were 41.0 ±5.8 ng/mL, 31.9 ± 8.8 ng/mL, and 29.5 ± 10.5 ng/mL for camphor, menthol, and methyl salicylate, respectively. The corresponding values for the 4-patch group were 26.8 ± 7.2 ng/mL, 19.0 ±5.4 ng/mL, and 16.8 ± 6.8 ng/mL. The harmonic mean terminal half-lives were 5.6 ± 1.3 hours, 4.7 ± 1.6 hours, and 3.0 ± 1.2 hours for camphor, menthol, and methyl salicylate, respectively. The 2-patch group had measurable but low plasma concentrations of each compound. Low-dose dermal application for an extended time results in low plasma concentrations of all 3 compounds. Four and 8 patches, when applied for 8 hours, gave measurable and nearly proportional plasma concentrations. Although unable to determine the absolute dermal bioavailability of these compounds, there appears to be relatively low systemic exposure to these potentially toxic compounds, even when an unrealistically large number of patches are applied for an unusually long time.

AB - Camphor, menthol, and methyl salicylate occur in numerous over-the-counter products. Although extensively used, there have been no estimates of human exposure following administration via dermal application. Furthermore, there is little information about the pharmacokinetics of those compounds. The authors report the plasma concentrations of the intact compounds as a function of dose following dermal patch application. Three groups of 8 subjects (4 male, 4 female) applied a different number of commercial patches (2, 4, or 8) to the skin for 8 hours. Plasma samples were assayed using sensitive and selective gas-chromatographic methods. For the 8-patch group, the average maximum plasma concentrations (Cmax ± SD) were 41.0 ±5.8 ng/mL, 31.9 ± 8.8 ng/mL, and 29.5 ± 10.5 ng/mL for camphor, menthol, and methyl salicylate, respectively. The corresponding values for the 4-patch group were 26.8 ± 7.2 ng/mL, 19.0 ±5.4 ng/mL, and 16.8 ± 6.8 ng/mL. The harmonic mean terminal half-lives were 5.6 ± 1.3 hours, 4.7 ± 1.6 hours, and 3.0 ± 1.2 hours for camphor, menthol, and methyl salicylate, respectively. The 2-patch group had measurable but low plasma concentrations of each compound. Low-dose dermal application for an extended time results in low plasma concentrations of all 3 compounds. Four and 8 patches, when applied for 8 hours, gave measurable and nearly proportional plasma concentrations. Although unable to determine the absolute dermal bioavailability of these compounds, there appears to be relatively low systemic exposure to these potentially toxic compounds, even when an unrealistically large number of patches are applied for an unusually long time.

KW - Absorption

KW - Camphor

KW - Dermal patches

KW - Menthol

KW - Methyl salicylate

KW - Toxicity

UR - http://www.scopus.com/inward/record.url?scp=4444265322&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4444265322&partnerID=8YFLogxK

U2 - 10.1177/0091270004268409

DO - 10.1177/0091270004268409

M3 - Article

C2 - 15342616

AN - SCOPUS:4444265322

VL - 44

SP - 1151

EP - 1157

JO - Journal of Clinical Pharmacology

JF - Journal of Clinical Pharmacology

SN - 0091-2700

IS - 10

ER -